Waldenström's macroglobulinemia front line treatment

por Tedeschi, Alessandra, Frustaci, Anna Maria
Publicado 2019

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia

por Frustaci, Anna Maria, Tedeschi, Alessandra, Picardi, Paola, Cairoli, Roberto, Montillo, Marco
Publicado 2015

Waldenstrom’s Macroglobulinemia: An Update

por Mazzucchelli, Maddalena, Frustaci, Anna Maria, Deodato, Marina, Cairoli, Roberto, Tedeschi, Alessandra
Publicado 2018

Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities

por Frustaci, Anna Maria, Deodato, Marina, Zamprogna, Giulia, Cairoli, Roberto, Montillo, Marco, Tedeschi, Alessandra
Publicado 2023

Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome...

por Trojani, Alessandra, Di Camillo, Barbara, Bossi, Luca Emanuele, Leuzzi, Livia, Greco, Antonino, Tedeschi, Alessandra, Frustaci, Anna Maria, Deodato, Marina, Zamprogna, Giulia, Beghini, Alessandro, Cairoli, Roberto
Publicado 2021

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort

por Reda, Gianluigi, Mattiello, Veronica, Frustaci, Anna Maria, Visentin, Andrea, Mauro, Francesca Romana, Innocenti, Idanna, Gentile, Massimo, Giannarelli, Diana, Noto, Alessandro, Cassin, Ramona, Neri, Antonino, Laurenti, Luca, Tedeschi, Alessandra
Publicado 2022

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial

por Scarfò, Lydia, Ferrari, Silvia, Frustaci, Anna Maria, Tani, Monica, Bari, Alessia, Scarano, Eloise, Colia, Maria, Ranghetti, Pamela, Angelillo, Piera, Ronchi, Paola, Ponzoni, Maurilio, Ferreri, Andrés J. M., Ghia, Paolo
Publicado 2022

COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study)

por Molica, Stefano, Laurenti, Luca, Ghia, Paolo, Coscia, Marta, Cuneo, Antonio, Gaidano, Gianluca, Mauro, Francesca, Frustaci, Anna Maria, Vallisa, Daniele, Pane, Fabrizio, Gualberti, Giuliana, Iannella, Emilia, Finsinger, Paola, Caira, Morena, Sportoletti, Paolo
Publicado 2021

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi

por Zamprogna, Giulia, Frustaci, Anna Maria, Travi, Giovanna, Borella, Chiara, Reda, Gianluigi, Motta, Marina, Deodato, Marina, Bossi, Elisa, Mattiello, Veronica, Ferrari, Maria Beatrice, Cotilli, Giulia, Gambacorti-Passerini, Carlo, Cairoli, Roberto, Puoti, Massimo, Tedeschi, Alessandra
Publicado 2023

S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME

por Frustaci, Anna Maria, Montillo, Marco, Rossi, Davide, Zinzani, Pier Luigi, Motta, Marina, Gaidano, Gianluca, Quaresmini, Giulia, Scarfò, Lydia, Pietrasanta, Daniela, Coscia, Marta, Deodato, Marina, Zamprogna, Giulia, Cairoli, Roberto, Stüssi, Georg, Zucca, Emanuele, Pileri, Stefano, Zenz, Thorsten, Tedeschi, Alessandra
Publicado 2023

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

por Autore, Francesco, Strati, Paolo, Innocenti, Idanna, Corrente, Francesco, Trentin, Livio, Cortelezzi, Agostino, Visco, Carlo, Coscia, Marta, Cuneo, Antonio, Gozzetti, Alessandro, Mauro, Francesca Romana, Frustaci, Anna Maria, Gentile, Massimo, Morabito, Fortunato, Molica, Stefano, Falcucci, Paolo, D’Arena, Giovanni, Murru, Roberta, Vincelli, Donatella, Efremov, Dimitar G, Ferretti, Antonietta, Rigolin, Gian Matteo, Vitale, Candida, Tisi, Maria Chiara, Reda, Gianluigi, Visentin, Andrea, Sica, Simona, Foà, Robin, Ferrajoli, Alessandra, Laurenti, Luca
Publicado 2019

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

por Mauro, Francesca Romana, Giannarelli, Diana, Visentin, Andrea, Reda, Gianluigi, Sportoletti, Paolo, Frustaci, Anna Maria, Chiarenza, Annalisa, Ciolli, Stefania, Vitale, Candida, Laurenti, Luca, De Paoli, Lorenzo, Murru, Roberta, Gentile, Massimo, Rigolin, Gian Matteo, Levato, Luciano, Giordano, Annamaria, Del Poeta, Giovanni, Stelitano, Caterina, Ielo, Claudia, Noto, Alessandro, Guarente, Valerio, Molica, Stefano, Coscia, Marta, Tedeschi, Alessandra, Gaidano, Gianluca, Cuneo, Antonio, Foà, Robin, Martelli, Maurizio, Girmenia, Corrado, Gentile, Giuseppe, Trentin, Livio
Publicado 2021

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

por Tedeschi, Alessandra, Frustaci, Anna Maria, Mauro, Francesca Romana, Chiarenza, Annalisa, Coscia, Marta, Ciolli, Stefania, Reda, Gianluigi, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Baratè, Claudia, Sportoletti, Paolo, Greco, Antonino, Borella, Chiara, Rossi, Valentina, Deodato, Marina, Biagi, Annalisa, Zamprogna, Giulia, Pelle, Angelo Curto, Lapietra, Gianfranco, Vitale, Candida, Morelli, Francesca, Cassin, Ramona, Fresa, Alberto, Cavalloni, Chiara, Postorino, Massimiliano, Ielo, Claudia, Cairoli, Roberto, Di Raimondo, Francesco, Montillo, Marco, Del Poeta, Giovanni
Publicado 2021

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

por Innocenti, Idanna, Reda, Gianluigi, Visentin, Andrea, Coscia, Marta, Motta, Marina, Murru, Roberta, Moia, Riccardo, Gentile, Massimo, Pennese, Elsa, Quaglia, Francesca Maria, Albano, Francesco, Cassin, Ramona, Deodato, Marina, Ielo, Claudia, Frustaci, Anna Maria, Piciocchi, Alfonso, Rughini, Arianna, Arena, Valentina, Di Sevo, Daniela, Tomasso, Annamaria, Autore, Francesco, Del Poeta, Giovanni, Scarfò, Lydia, Mauro, Francesca Romana, Tedeschi, Alessandra, Trentin, Livio, Pompili, Maurizio, Foà, Robin, Ghia, Paolo, Cuneo, Antonio, Laurenti, Luca
Publicado 2022

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

por Frustaci, Anna Maria, Del Poeta, Giovanni, Visentin, Andrea, Sportoletti, Paolo, Fresa, Alberto, Vitale, Candida, Murru, Roberta, Chiarenza, Annalisa, Sanna, Alessandro, Mauro, Francesca Romana, Reda, Gianluigi, Gentile, Massimo, Varettoni, Marzia, Baratè, Claudia, Borella, Chiara, Greco, Antonino, Deodato, Marina, Zamprogna, Giulia, Laureana, Roberta, Cipiciani, Alessandra, Galitzia, Andrea, Curto Pelle, Angelo, Morelli, Francesca, Malvisi, Lucio, Coscia, Marta, Laurenti, Luca, Trentin, Livio, Montillo, Marco, Cairoli, Roberto, Tedeschi, Alessandra
Publicado 2022

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

por Bonfiglio, Silvia, Sutton, Lesley-Ann, Ljungström, Viktor, Capasso, Antonella, Pandzic, Tatjana, Weström, Simone, Foroughi-Asl, Hassan, Skaftason, Aron, Gellerbring, Anna, Lyander, Anna, Gandini, Francesca, Gaidano, Gianluca, Trentin, Livio, Bonello, Lisa, Reda, Gianluigi, Bödör, Csaba, Stavroyianni, Niki, Tam, Constantine S., Marasca, Roberto, Forconi, Francesco, Panayiotidis, Panayiotis, Ringshausen, Ingo, Jaksic, Ozren, Frustaci, Anna Maria, Iyengar, Sunil, Coscia, Marta, Mulligan, Stephen P., Ysebaert, Loïc, Strugov, Vladimir, Pavlovsky, Carolina, Walewska, Renata, Österborg, Anders, Cortese, Diego, Ranghetti, Pamela, Baliakas, Panagiotis, Stamatopoulos, Kostas, Scarfò, Lydia, Rosenquist, Richard, Ghia, Paolo
Publicado 2023